Fulcrum Therapeutics (FULC) Asset Utilization Ratio (2020 - 2024)
Historic Asset Utilization Ratio for Fulcrum Therapeutics (FULC) over the last 6 years, with Q1 2025 value amounting to 0.32.
- Fulcrum Therapeutics' Asset Utilization Ratio rose 300439.86% to 0.32 in Q1 2025 from the same period last year, while for Mar 2025 it was 0.32, marking a year-over-year increase of 300439.86%. This contributed to the annual value of 0.31 for FY2024, which is 256481.69% up from last year.
- As of Q1 2025, Fulcrum Therapeutics' Asset Utilization Ratio stood at 0.32, which was up 300439.86% from 0.3 recorded in Q4 2024.
- In the past 5 years, Fulcrum Therapeutics' Asset Utilization Ratio ranged from a high of 0.32 in Q1 2025 and a low of 0.01 during Q3 2023
- Its 5-year average for Asset Utilization Ratio is 0.11, with a median of 0.07 in 2022.
- As far as peak fluctuations go, Fulcrum Therapeutics' Asset Utilization Ratio tumbled by 8593.74% in 2023, and later soared by 306426.9% in 2024.
- Fulcrum Therapeutics' Asset Utilization Ratio (Quarter) stood at 0.08 in 2021, then plummeted by 65.79% to 0.03 in 2022, then crashed by 60.89% to 0.01 in 2023, then soared by 2735.39% to 0.3 in 2024, then rose by 7.22% to 0.32 in 2025.
- Its Asset Utilization Ratio was 0.32 in Q1 2025, compared to 0.3 in Q4 2024 and 0.28 in Q3 2024.